A Randomized, Double-Blind, Placebo-Controlled, Parallel

  • Green, Jaime (PI)

Project: Research project

Project Details

Description

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Phase 3 Study of the Safety, Tolerability, and Efficacy of CMX001 for the Prevention of Cytomegalovirus (CMV) Infection in CMVseropositive (R+)
StatusActive
Effective start/end date7/15/1312/31/20

Funding

  • Chimerix, Inc.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.